ResApp Health recently announced its planned sale to Pfizer Australia, a wholly owned subsidiary of Pfizer Inc. Pfizer agrees it would acquire 100% of the shares for AUD $0.115 / share, for a total equity value of...more
APPLE, INC. v. QUALCOMM, INC.
Before Newman, Prost, and Stoll. Appeal from the Patent Trial and Appeal Board.
Summary: Apple lacked standing to appeal an IPR decision upholding patents that Apple licenses from...more
11/15/2021
/ Appeals ,
Apple ,
Article III ,
Inter Partes Review (IPR) Proceeding ,
IP License ,
License Agreements ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Qualcomm ,
Standing